0.00Open0.05Pre Close0 Volume502 Open Interest12.00Strike Price0.00Turnover0.00%IV-0.99%PremiumDec 20, 2024Expiry Date0.17Intrinsic Value100Multiplier-28DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma243.40Leverage Ratio--Theta--Rho--Eff Leverage--Vega
CorMedix Stock Discussion
Until it wasn’t… Joe Todisco’s leadership, as CEO, troubles me.
CORMEDIX INC. ANNOUNCES PRELIMINARY FOURTH QUARTER 2024 RESULTS AND PROVIDES BUSINESS UPDATE - CorMedix | Prevention of cardiac, renal and infectious diseases
$72-78mm spending in 2025, “…largely driven by R&D,” they said?
“[Co...
Time to call it a day
No comment yet